A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis Metastasis and chemoresistance in cancer are linked phenomena, but the molecular basis for this link is unknown. Scientists uncovered a network of paracrine signals between carcinoma, myeloid, and endothelial cells that drives both processes in breast cancer. [Cell] Abstract
Acetylation-Dependent Regulation of Skp2 Function Although the underlying molecular mechanisms remain elusive, cytoplasmic Skp2 correlates with more aggressive forms of breast and prostate cancers. Scientists identified an acetylation-dependent regulatory mechanism governing Skp2 oncogenic function and provide insight into how cytoplasmic Skp2 controls cellular migration. [Cell] Abstract
HGFK1 Inhibits Bone Metastasis in Breast Cancer through the TAK1/p38 MAPK Signaling Pathway Researchers showed, for the first time, that the kringle 1 domain of human hepatocyte growth factor (HGFK1) significantly inhibits the metastasis of breast cancer to bone by activating the TAK1/p38 mitogen-activated protein kinase (MAPK) signaling pathway and inhibiting receptor activator of nuclear factor-κB expression. [Cancer Gene Ther] Abstract
CRT and ADC Therapeutics Join Forces on Antibody Drug Conjugates Cancer Research Technology (CRT) and Switzerland-based ADC Therapeutics Sarl announced that they have signed agreements to develop cancer treatments called Antibody Drug Conjugates (ADCs) using CRT antibodies and peptides, and ADCT’s ‘warhead’ and linker chemistries. [Cancer Research Technology] Press Release
Cancer Therapeutics CRC Presents Data on Second Targeted Drug for Cancer Cancer Therapeutics announced the validation and performance of a new targeted drug, CTx-294886, in combination with Avastin™ in a preclinical model of breast cancer. At the same time the Company announced that it has developed a new High Throughput Screening platform for the identification of small molecule inhibitors of protein ubiquitination. [Cancer Therapeutics CRC] Press Release
Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Mammary Cell News? Click here to submit!